<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In patients with <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e> caused by long-term red blood cell transfusions is an important factor for comorbidity especially in low-risk <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>In this report we present the results of a comparative study based on colony formation assays of hematopoietic cells in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patients with and without <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>We demonstrate that <z:e sem="disease" ids="C0282193" disease_type="Disease or Syndrome" abbrv="">iron overload</z:e> suppresses the proliferation of erythroid progenitors cells (BFU-E), while the myeloid compartment (CFU-GM) was not found to be affected </plain></SENT>
<SENT sid="3" pm="."><plain>Even patients with slightly elevated ferritin values show an impaired proliferation capacity in comparison to patients with <z:mpath ids='MPATH_458'>normal</z:mpath> ferritin levels </plain></SENT>
<SENT sid="4" pm="."><plain>Furthermore, we show that this negative impact is reversible by sufficient iron chelation therapy </plain></SENT>
</text></document>